While the expression of p16 in laryngeal cancer did not demonstrate a significant association with tumor staging or survival time, it remains possible that p16 may still play a role in the pathogenesis and prognosis assessment of laryngeal cancer. The gene discussed is CDKN2A; the disease is neoplasm.